Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Millie Long

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Lancet. Gastroenterology & Hepatology|January 16, 2026
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trialMillie Long, Jessica R Allegretti, Silvio Danese, et al.
Drug Safety|July 15, 2024
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing ReportsUma Mahadevan, Gweneth Levy, Lianne Gensler, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2023
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learnedTimothy Beukelman, Lang Chen, Narender Annapureddy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension AnalysesAlessandro Armuzzi, Raymond K Cross, Gary R Lichtenstein, et al.
Inflammatory Bowel Diseases|July 22, 2024
Risankizumab Is Effective for The Management of Crohn's Disease of the PouchMaia Kayal, Elizabeth A Spencer, Matthew Smyth, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trialLaurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
Inflammatory Bowel Diseases|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
The American Journal of Gastroenterology|August 27, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Journal of Crohn'S & Colitis|September 7, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Lancet. Gastroenterology & Hepatology|January 16, 2026
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trialMillie Long, Jessica R Allegretti, Silvio Danese, et al.
Drug Safety|July 15, 2024
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing ReportsUma Mahadevan, Gweneth Levy, Lianne Gensler, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2023
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learnedTimothy Beukelman, Lang Chen, Narender Annapureddy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension AnalysesAlessandro Armuzzi, Raymond K Cross, Gary R Lichtenstein, et al.
Inflammatory Bowel Diseases|July 22, 2024
Risankizumab Is Effective for The Management of Crohn's Disease of the PouchMaia Kayal, Elizabeth A Spencer, Matthew Smyth, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trialLaurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
Inflammatory Bowel Diseases|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
The American Journal of Gastroenterology|August 27, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Journal of Crohn'S & Colitis|September 7, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Pageof 4